Ryan C. Fields

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

Li Ding, Ilya Shmulevich, Matti Nykter, 2018, Cell reports.

NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Brian R. Gastman, Kenneth K. Tanabe, Christopher K. Bichakjian, 2016 .

Clonal Architectures and Driver Mutations in Metastatic Melanomas

Li Ding, Malachi Griffith, Joshua F. McMichael, 2014, PloS one.

Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles

Samuel A. Wickline, Ye Bi, William E. Gillanders, 2019, Oncotarget.